177Lu-FAP-2286
N/A
Report date: 2026/03/12 20:00:16
Base Information
Drug Name177Lu-FAP-2286
Drug Alias Name
Classification +[4]
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory +[6]
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaN/A
Originator Companies3B Pharmaceuticals GmbH
China Registration ClassN/A
Develop Information
Active CompaniesClovis Oncology IncNovartis Pharma Ag
Inactive Companies3B Pharmaceuticals GmbH
Active Indications
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A